Lonza Group Ag Cash Flow from Operating Activities 2012-2023 | LZAGY
Lonza Group Ag annual/quarterly cash flow from operating activities history and growth rate from 2012 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Lonza Group Ag cash flow from operating activities for the quarter ending December 31, 2023 was $1.543B, a 156% increase year-over-year.
- Lonza Group Ag cash flow from operating activities for the twelve months ending December 31, 2023 was $4.254B, a 30.86% increase year-over-year.
- Lonza Group Ag annual cash flow from operating activities for 2022 was $1.069B, a 19.73% decline from 2021.
- Lonza Group Ag annual cash flow from operating activities for 2021 was $1.332B, a 10.48% increase from 2020.
- Lonza Group Ag annual cash flow from operating activities for 2020 was $1.205B, a 21.45% increase from 2019.
| Lonza Group Ag Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2022 | $1,069 |
| 2021 | $1,332 |
| 2020 | $1,205 |
| 2019 | $992 |
| 2017 | $877 |
| 2016 | $764 |
| 2015 | $771 |
| 2014 | $529 |
| 2013 | $563 |
| 2012 | $758 |
| 2011 | $250 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $40.064B | $7.478B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.990B | 23.17 |
| Stryker (SYK) | United States | $129.721B | 31.07 |
| Boston Scientific (BSX) | United States | $110.032B | 35.05 |
| Medtronic (MDT) | Ireland | $107.023B | 15.47 |
| EssilorLuxottica (ESLOY) | France | $100.473B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.264B | 27.93 |
| ResMed (RMD) | United States | $30.754B | 28.87 |
| Koninklijke Philips (PHG) | Netherlands | $25.408B | 19.68 |
| Terumo (TRUMY) | Japan | $25.118B | 35.47 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.544B | 15.04 |
| Baxter (BAX) | United States | $17.035B | 12.11 |
| Insulet (PODD) | United States | $12.323B | 54.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.938B | 0.00 |
| Demant (WILYY) | Denmark | $10.259B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.044B | 26.31 |
| BellRing Brands (BRBR) | United States | $7.479B | 35.18 |
| Lantheus Holdings (LNTH) | United States | $5.581B | 13.91 |
| GN Store Nord (GNNDY) | Denmark | $4.717B | 26.49 |
| Haemonetics (HAE) | United States | $4.304B | 21.27 |
| Perrigo (PRGO) | Ireland | $3.758B | 11.39 |
| Envista Holdings (NVST) | United States | $3.245B | 13.39 |
| Prestige Consumer Healthcare (PBH) | United States | $3.135B | 14.92 |
| QuidelOrtho (QDEL) | United States | $2.960B | 16.43 |
| Neogen (NEOG) | United States | $2.857B | 27.48 |
| TG Therapeutics (TGTX) | United States | $2.610B | 73.43 |
| ICU Medical (ICUI) | United States | $2.523B | 22.26 |
| Green Thumb Industries (GTBIF) | United States | $2.367B | 46.88 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.240B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.131B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.768B | 51.82 |
| Warby Parker (WRBY) | United States | $1.729B | 0.00 |
| InMode (INMD) | Israel | $1.585B | 8.42 |
| Verano Holdings (VRNOF) | United States | $1.463B | 0.00 |
| Owens & Minor (OMI) | United States | $1.320B | 11.50 |
| AdaptHealth (AHCO) | United States | $1.291B | 9.59 |
| National Vision Holdings (EYE) | United States | $1.150B | 36.60 |
| AtriCure (ATRC) | United States | $1.059B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.001B | 0.00 |
| Evolus (EOLS) | United States | $0.789B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.721B | 15.35 |
| Canopy Growth (CGC) | Canada | $0.655B | 0.00 |
| Quanterix (QTRX) | United States | $0.625B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.624B | 0.00 |
| Valneva SE (VALN) | France | $0.620B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.619B | 14.56 |
| PetIQ (PETQ) | United States | $0.612B | 19.78 |
| Surmodics (SRDX) | United States | $0.600B | 37.59 |
| ZimVie (ZIMV) | United States | $0.452B | 38.49 |
| TerrAscend (TSNDF) | Canada | $0.449B | 0.00 |
| Jin Medical (ZJYL) | China | $0.425B | 0.00 |
| Biote (BTMD) | United States | $0.407B | 9.37 |
| OraSure Technologies (OSUR) | United States | $0.348B | 11.19 |
| Cerus (CERS) | United States | $0.338B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.335B | 0.00 |
| Zynex (ZYXI) | United States | $0.315B | 43.13 |
| Viemed Healthcare (VMD) | United States | $0.280B | 27.69 |
| MacroGenics (MGNX) | United States | $0.266B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.252B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.92 |
| TriSalus Life Sciences (TLSI) | United States | $0.202B | 0.00 |
| High Tide (HITI) | Canada | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.192B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.177B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| Quipt Home Medical (QIPT) | United States | $0.146B | 0.00 |
| Veru (VERU) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 19.98 |
| InterCure (INCR) | Israel | $0.134B | 22.61 |
| Jushi Holdings (JUSHF) | United States | $0.119B | 0.00 |
| Brainsway (BWAY) | Israel | $0.109B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.109B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 8.46 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.086B | 0.00 |
| MariMed (MRMD) | United States | $0.081B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.072B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.044B | 2.90 |
| United-Guardian (UG) | United States | $0.043B | 15.45 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Innovative Eyewear (LUCY) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |